BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, July 18, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Trump administration impacts continue to roil the life sciences sector
Breaking News: Self-amplifying mRNA technology underscored for next big pandemic
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
NGD-95-1 demonstrates safety in phase I
Aug. 30, 1996
More squalene synthase inhibitors from Pfizer
Aug. 30, 1996
Xenical to be marketed in 1997
Aug. 30, 1996
SDZ-266806: A novel squalene synthase inhibitor
Aug. 30, 1996
Estrogenic compounds from Sankyo
Aug. 30, 1996
Prophylactic tibolone shown effective in 2 year study
Aug. 30, 1996
Columbia Laboratories granted U.S. patent for Crinone technology
Aug. 23, 1996
Astra's Atmos launched in Sweden
Aug. 23, 1996
Humatrope approved for new indication in U.S.
Aug. 23, 1996
Update on Biotech Holdings' Diab II
Aug. 23, 1996
Previous
1
2
…
1741
1742
1743
1744
1745
1746
1747
1748
1749
…
1769
1770
Next
RSS